English

Windtree Therapeutics, Inc.

EDGAR

WINT Current report (8-K) · filed 2026-01-07

164 filing records in this dataset, filed from 1996-05-15 to 2026-01-07. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

0 iso4217-usd

2019 Q4 · iso4217-usd

Exact inputs and evidence

Revenue: 198000 iso4217-usd Source
Revenue: 198000 iso4217-usd Source

Operating cash flow

-5.46 million iso4217-usd

2019 Q4 · iso4217-usd

Exact inputs and evidence

Operating Cash Flow: -24663000 iso4217-usd Source
Operating Cash Flow: -19204000 iso4217-usd Source

Free cash flow

-5.52 million iso4217-usd

2019 Q4 · iso4217-usd

Exact inputs and evidence

Operating Cash Flow: -24663000 iso4217-usd Source
Operating Cash Flow: -19204000 iso4217-usd Source
Capital Expenditure: 191000 iso4217-usd Source
Capital Expenditure: 129000 iso4217-usd Source

Cash and cash equivalents: 200 thousand USD 2025-09-30 Source
Exact value

200000 USD
Long-term debt including current maturities: 20.3 million U001 2014-12-31 Source
Exact value

20302000 U001
Shares outstanding: 33.6 million shares 2025-09-30 Source
Exact value

33634220 shares

Reported share-count change

1,337.10% · 31.3 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

2340428 shares · 2024-09-30· Source
33634220 shares · 2025-09-30· Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-01-07.

Financial data available through: 2024-12-31.

Coverage by financial measure

Revenue: 5 of 11 periods available· newest 2019-12-31
Operating income: 5 of 11 periods available· newest 2024-12-31
Net income: 5 of 11 periods available· newest 2024-12-31
Operating cash flow: 5 of 11 periods available· newest 2024-12-31
Capital expenditure: 5 of 11 periods available· newest 2024-12-31
Total assets: 5 of 11 periods available· newest 2024-12-31
Total liabilities: 5 of 11 periods available· newest 2024-12-31
Current assets: 5 of 11 periods available· newest 2024-12-31
Current liabilities: 5 of 11 periods available· newest 2024-12-31
Cash and cash equivalents: 5 of 11 periods available· newest 2024-12-31
Long-term debt including current maturities: 1 of 11 periods available· newest 2014-12-31
Shares outstanding: 5 of 11 periods available· newest 2024-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
+USD 18.5 million

Prior period

−USD 20.3 million

2023-01-01 – 2023-12-31
Current period

−USD 1.8 million

2024-01-01 – 2024-12-31

Exact inputs and evidence

-1800000 − -20300000 = 18500000 USD

-20300000 USD · 2023-01-01 – 2023-12-31
Inspect prior input Prior source
-1800000 USD · 2024-01-01 – 2024-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Windtree Therapeutics, Inc. · 2024-12-31 Windtree Therapeutics, Inc. (edgar:946486) Year-over-year change in Net income: 18500000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T14:53:36Z Snapshot: 5003797f5474aa120b871d98dfbbc6d4748d8ea1fc18592f3259e4bac817ecb0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/946486?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -1800000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946486/000143774925012093/wint20241231_10k.htm#2549523 Filing: 000143774925012093 Input fundies:NetIncome: -20300000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946486/000143774925012093/wint20241231_10k.htm#2549857 Filing: 000143774925012093
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 1.97 million

Prior period

−USD 13.44 million

2023-01-01 – 2023-12-31
Current period

−USD 15.4 million

2024-01-01 – 2024-12-31

Exact inputs and evidence

-15402000 − -13437000 = -1965000 USD

-13437000 USD · 2023-01-01 – 2023-12-31
Inspect prior input Prior source
-15402000 USD · 2024-01-01 – 2024-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Windtree Therapeutics, Inc. · 2024-12-31 Windtree Therapeutics, Inc. (edgar:946486) Year-over-year change in Operating cash flow: -1965000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T14:53:36Z Snapshot: 5003797f5474aa120b871d98dfbbc6d4748d8ea1fc18592f3259e4bac817ecb0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/946486?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -15402000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946486/000143774925012093/wint20241231_10k.htm#2465770 Filing: 000143774925012093 Input fundies:OperatingCashFlow: -13437000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946486/000143774925012093/wint20241231_10k.htm#2466590 Filing: 000143774925012093
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-20%

Prior period

USD 15,000

2023-01-01 – 2023-12-31
Current period

USD 12,000

2024-01-01 – 2024-12-31

Exact inputs and evidence

12000 − 15000 = -3000 USD

15000 USD · 2023-01-01 – 2023-12-31
Inspect prior input Prior source
12000 USD · 2024-01-01 – 2024-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · Windtree Therapeutics, Inc. · 2024-12-31 Windtree Therapeutics, Inc. (edgar:946486) Year-over-year change in Capital expenditure: -3000 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T14:53:36Z Snapshot: 5003797f5474aa120b871d98dfbbc6d4748d8ea1fc18592f3259e4bac817ecb0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/946486?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 12000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946486/000143774925012093/wint20241231_10k.htm#2469169 Filing: 000143774925012093 Input fundies:CapitalExpenditure: 15000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946486/000143774925012093/wint20241231_10k.htm#2469976 Filing: 000143774925012093
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2019 2019-01-01 – 2019-12-31

Revenue iso4217-usd 198,000 100% of revenue
Operating costs Derived Unavailable An input is unavailable.
Operating income Unavailable An input is unavailable.
Tax, interest and other Derived Unavailable An input is unavailable.
Net income Unavailable An input is unavailable.

Cash

Operating cash flow Unavailable An input is unavailable.
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2015 Not shown: operating income or net income is not reported.
2016 Not shown: operating income or net income is not reported.
2017 Not shown: operating income or net income is not reported.
2018 Not shown: operating income or net income is not reported.
2019 Not shown: operating income or net income is not reported.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2015 2015-01-01 – 2015-12-31	987000	Unavailable	Unavailable	Unavailable	Unavailable	Unavailable	Source 2015-01-01 – 2015-12-31: 987000 iso4217-usd Inspect Revenue Open source
2016 2016-01-01 – 2016-12-31	2042000	Unavailable	Unavailable	Unavailable	Unavailable	Unavailable	Source 2016-01-01 – 2016-12-31: 2042000 iso4217-usd Inspect Revenue Open source
2017 2017-01-01 – 2017-12-31	1485000	Unavailable	Unavailable	Unavailable	Unavailable	Unavailable	Source 2017-01-01 – 2017-12-31: 1485000 iso4217-usd Inspect Revenue Open source
2018 2018-01-01 – 2018-12-31	1788000	Unavailable	Unavailable	Unavailable	Unavailable	Unavailable	Source 2018-01-01 – 2018-12-31: 1788000 iso4217-usd Inspect Revenue Open source
2019 2019-01-01 – 2019-12-31	198000	Unavailable	Unavailable	Unavailable	Unavailable	Unavailable	Source 2019-01-01 – 2019-12-31: 198000 iso4217-usd Inspect Revenue Open source

Amounts are exact, in iso4217-usd.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

iso4217-usd 198K 2019

Values and sources

Revenue values and source evidence
Period	Series	Value(iso4217-usd)	Source evidence
20152015-12-31	Revenue	987000	Revenue: 987000 Open source
20162016-12-31	Revenue	2042000	Revenue: 2042000 Open source
20172017-12-31	Revenue	1485000	Revenue: 1485000 Open source
20182018-12-31	Revenue	1788000	Revenue: 1788000 Open source
20192019-12-31	Revenue	198000	Revenue: 198000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-88.9% 2019

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20152015-12-31	Year over year	No prior comparable period	Revenue: 987000 Open source
20162016-12-31	Year over year	106.9%	Revenue: 2042000 Open source Revenue: 987000 Open source
20172017-12-31	Year over year	-27.3%	Revenue: 1485000 Open source Revenue: 2042000 Open source
20182018-12-31	Year over year	20.4%	Revenue: 1788000 Open source Revenue: 1485000 Open source
20192019-12-31	Year over year	-88.9%	Revenue: 198000 Open source Revenue: 1788000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
2015-12-31	Operating margin	Not reported	Revenue: 987000 Open source
2016-12-31	Operating margin	Not reported	Revenue: 2042000 Open source
2017-12-31	Operating margin	Not reported	Revenue: 1485000 Open source
2018-12-31	Operating margin	Not reported	Revenue: 1788000 Open source
2019-12-31	Operating margin	Not reported	Revenue: 198000 Open source
2015-12-31	Net margin	Not reported	Revenue: 987000 Open source
2016-12-31	Net margin	Not reported	Revenue: 2042000 Open source
2017-12-31	Net margin	Not reported	Revenue: 1485000 Open source
2018-12-31	Net margin	Not reported	Revenue: 1788000 Open source
2019-12-31	Net margin	Not reported	Revenue: 198000 Open source
20152015-12-31	Free cash flow margin	Not reported	Revenue: 987000 Open source
20162016-12-31	Free cash flow margin	Not reported	Revenue: 2042000 Open source
20172017-12-31	Free cash flow margin	Not reported	Revenue: 1485000 Open source
20182018-12-31	Free cash flow margin	Not reported	Revenue: 1788000 Open source
20192019-12-31	Free cash flow margin	Not reported	Revenue: 198000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

Not enough comparable data to show this history.

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(iso4217-usd)	Source evidence
20152015-12-31	Operating cash flow	Not reported	No source recorded
20162016-12-31	Operating cash flow	Not reported	No source recorded
20172017-12-31	Operating cash flow	Not reported	No source recorded
20182018-12-31	Operating cash flow	Not reported	No source recorded
20192019-12-31	Operating cash flow	Not reported	No source recorded

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value	Source evidence
20152015-12-31	Free cash flow	Unavailable	No source recorded
20162016-12-31	Free cash flow	Unavailable	No source recorded
20172017-12-31	Free cash flow	Unavailable	No source recorded
20182018-12-31	Free cash flow	Unavailable	No source recorded
20192019-12-31	Free cash flow	Unavailable	No source recorded

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2015-12-31	Liabilities / assets	Not reported	No source recorded
2016-12-31	Liabilities / assets	Not reported	No source recorded
2017-12-31	Liabilities / assets	Not reported	No source recorded
2018-12-31	Liabilities / assets	Not reported	No source recorded
2019-12-31	Liabilities / assets	Not reported	No source recorded

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2015-12-31	Current assets / current liabilities	Not reported	No source recorded
2016-12-31	Current assets / current liabilities	Not reported	No source recorded
2017-12-31	Current assets / current liabilities	Not reported	No source recorded
2018-12-31	Current assets / current liabilities	Not reported	No source recorded
2019-12-31	Current assets / current liabilities	Not reported	No source recorded

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2020 2020-01-01 – 2020-12-31	−USD 32.6 million Exact value Exact value: -32600000 USD 2020-01-01 – 2020-12-31: -32600000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Windtree Therapeutics, Inc. · 2020-12-31 Windtree Therapeutics, Inc. (edgar:946486) Net Income: -32600000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T14:53:36Z Snapshot: 5003797f5474aa120b871d98dfbbc6d4748d8ea1fc18592f3259e4bac817ecb0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/946486/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -32600000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946486/000143774922007757/wint20211231_10k.htm#1634355 Filing: 000143774922007757 The citation records this snapshot. The page link may show a newer release later.	−USD 25.32 million Exact value Exact value: -25315000 USD 2020-01-01 – 2020-12-31: -25315000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Windtree Therapeutics, Inc. · 2020-12-31 Windtree Therapeutics, Inc. (edgar:946486) Operating Cash Flow: -25315000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T14:53:36Z Snapshot: 5003797f5474aa120b871d98dfbbc6d4748d8ea1fc18592f3259e4bac817ecb0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/946486/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -25315000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946486/000143774922007757/wint20211231_10k.htm#1582675 Filing: 000143774922007757 The citation records this snapshot. The page link may show a newer release later.	USD 291,000 Exact value Exact value: 291000 USD 2020-01-01 – 2020-12-31: 291000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Windtree Therapeutics, Inc. · 2020-12-31 Windtree Therapeutics, Inc. (edgar:946486) Capital Expenditure: 291000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T14:53:36Z Snapshot: 5003797f5474aa120b871d98dfbbc6d4748d8ea1fc18592f3259e4bac817ecb0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/946486/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 291000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946486/000143774922007757/wint20211231_10k.htm#1586243 Filing: 000143774922007757 The citation records this snapshot. The page link may show a newer release later.	−USD 25.61 million Calculation and evidence -25315000 − 291000 USD Exact free cash flow: -25606000 USD 2020-01-01 – 2020-12-31: -25315000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 291000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Windtree Therapeutics, Inc. · 2020-12-31 Windtree Therapeutics, Inc. (edgar:946486) Free cash flow: -25606000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T14:53:36Z Snapshot: 5003797f5474aa120b871d98dfbbc6d4748d8ea1fc18592f3259e4bac817ecb0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/946486?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -25315000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946486/000143774922007757/wint20211231_10k.htm#1582675 Filing: 000143774922007757 Input fundies:CapitalExpenditure: 291000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946486/000143774922007757/wint20211231_10k.htm#1586243 Filing: 000143774922007757 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 67.6 million Exact value Exact value: -67600000 USD 2021-01-01 – 2021-12-31: -67600000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Windtree Therapeutics, Inc. · 2021-12-31 Windtree Therapeutics, Inc. (edgar:946486) Net Income: -67600000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T14:53:36Z Snapshot: 5003797f5474aa120b871d98dfbbc6d4748d8ea1fc18592f3259e4bac817ecb0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/946486/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -67600000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946486/000143774923008864/wint20221231_10k.htm#1735889 Filing: 000143774923008864 The citation records this snapshot. The page link may show a newer release later.	−USD 23.66 million Exact value Exact value: -23664000 USD 2021-01-01 – 2021-12-31: -23664000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Windtree Therapeutics, Inc. · 2021-12-31 Windtree Therapeutics, Inc. (edgar:946486) Operating Cash Flow: -23664000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T14:53:36Z Snapshot: 5003797f5474aa120b871d98dfbbc6d4748d8ea1fc18592f3259e4bac817ecb0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/946486/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -23664000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946486/000143774923008864/wint20221231_10k.htm#1686382 Filing: 000143774923008864 The citation records this snapshot. The page link may show a newer release later.	USD 279,000 Exact value Exact value: 279000 USD 2021-01-01 – 2021-12-31: 279000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Windtree Therapeutics, Inc. · 2021-12-31 Windtree Therapeutics, Inc. (edgar:946486) Capital Expenditure: 279000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T14:53:36Z Snapshot: 5003797f5474aa120b871d98dfbbc6d4748d8ea1fc18592f3259e4bac817ecb0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/946486/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 279000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946486/000143774923008864/wint20221231_10k.htm#1691464 Filing: 000143774923008864 The citation records this snapshot. The page link may show a newer release later.	−USD 23.94 million Calculation and evidence -23664000 − 279000 USD Exact free cash flow: -23943000 USD 2021-01-01 – 2021-12-31: -23664000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 279000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Windtree Therapeutics, Inc. · 2021-12-31 Windtree Therapeutics, Inc. (edgar:946486) Free cash flow: -23943000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T14:53:36Z Snapshot: 5003797f5474aa120b871d98dfbbc6d4748d8ea1fc18592f3259e4bac817ecb0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/946486?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -23664000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946486/000143774923008864/wint20221231_10k.htm#1686382 Filing: 000143774923008864 Input fundies:CapitalExpenditure: 279000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946486/000143774923008864/wint20221231_10k.htm#1691464 Filing: 000143774923008864 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 39.2 million Exact value Exact value: -39200000 USD 2022-01-01 – 2022-12-31: -39200000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Windtree Therapeutics, Inc. · 2022-12-31 Windtree Therapeutics, Inc. (edgar:946486) Net Income: -39200000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T14:53:36Z Snapshot: 5003797f5474aa120b871d98dfbbc6d4748d8ea1fc18592f3259e4bac817ecb0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/946486/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -39200000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946486/000143774925004006/wint20250207_s1.htm#2411119 Filing: 000143774925004006 The citation records this snapshot. The page link may show a newer release later.	−USD 19.45 million Exact value Exact value: -19452000 USD 2022-01-01 – 2022-12-31: -19452000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Windtree Therapeutics, Inc. · 2022-12-31 Windtree Therapeutics, Inc. (edgar:946486) Operating Cash Flow: -19452000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T14:53:36Z Snapshot: 5003797f5474aa120b871d98dfbbc6d4748d8ea1fc18592f3259e4bac817ecb0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/946486/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -19452000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946486/000143774925004006/wint20250207_s1.htm#2358957 Filing: 000143774925004006 The citation records this snapshot. The page link may show a newer release later.	USD 13,000 Exact value Exact value: 13000 USD 2022-01-01 – 2022-12-31: 13000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Windtree Therapeutics, Inc. · 2022-12-31 Windtree Therapeutics, Inc. (edgar:946486) Capital Expenditure: 13000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T14:53:36Z Snapshot: 5003797f5474aa120b871d98dfbbc6d4748d8ea1fc18592f3259e4bac817ecb0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/946486/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 13000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946486/000143774925004006/wint20250207_s1.htm#2364351 Filing: 000143774925004006 The citation records this snapshot. The page link may show a newer release later.	−USD 19.47 million Calculation and evidence -19452000 − 13000 USD Exact free cash flow: -19465000 USD 2022-01-01 – 2022-12-31: -19452000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 13000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Windtree Therapeutics, Inc. · 2022-12-31 Windtree Therapeutics, Inc. (edgar:946486) Free cash flow: -19465000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T14:53:36Z Snapshot: 5003797f5474aa120b871d98dfbbc6d4748d8ea1fc18592f3259e4bac817ecb0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/946486?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -19452000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946486/000143774925004006/wint20250207_s1.htm#2358957 Filing: 000143774925004006 Input fundies:CapitalExpenditure: 13000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946486/000143774925004006/wint20250207_s1.htm#2364351 Filing: 000143774925004006 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 20.3 million Exact value Exact value: -20300000 USD 2023-01-01 – 2023-12-31: -20300000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Windtree Therapeutics, Inc. · 2023-12-31 Windtree Therapeutics, Inc. (edgar:946486) Net Income: -20300000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T14:53:36Z Snapshot: 5003797f5474aa120b871d98dfbbc6d4748d8ea1fc18592f3259e4bac817ecb0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/946486/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -20300000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946486/000143774925012093/wint20241231_10k.htm#2549857 Filing: 000143774925012093 The citation records this snapshot. The page link may show a newer release later.	−USD 13.44 million Exact value Exact value: -13437000 USD 2023-01-01 – 2023-12-31: -13437000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Windtree Therapeutics, Inc. · 2023-12-31 Windtree Therapeutics, Inc. (edgar:946486) Operating Cash Flow: -13437000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T14:53:36Z Snapshot: 5003797f5474aa120b871d98dfbbc6d4748d8ea1fc18592f3259e4bac817ecb0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/946486/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -13437000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946486/000143774925012093/wint20241231_10k.htm#2466590 Filing: 000143774925012093 The citation records this snapshot. The page link may show a newer release later.	USD 15,000 Exact value Exact value: 15000 USD 2023-01-01 – 2023-12-31: 15000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Windtree Therapeutics, Inc. · 2023-12-31 Windtree Therapeutics, Inc. (edgar:946486) Capital Expenditure: 15000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T14:53:36Z Snapshot: 5003797f5474aa120b871d98dfbbc6d4748d8ea1fc18592f3259e4bac817ecb0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/946486/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 15000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946486/000143774925012093/wint20241231_10k.htm#2469976 Filing: 000143774925012093 The citation records this snapshot. The page link may show a newer release later.	−USD 13.45 million Calculation and evidence -13437000 − 15000 USD Exact free cash flow: -13452000 USD 2023-01-01 – 2023-12-31: -13437000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 15000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Windtree Therapeutics, Inc. · 2023-12-31 Windtree Therapeutics, Inc. (edgar:946486) Free cash flow: -13452000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T14:53:36Z Snapshot: 5003797f5474aa120b871d98dfbbc6d4748d8ea1fc18592f3259e4bac817ecb0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/946486?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -13437000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946486/000143774925012093/wint20241231_10k.htm#2466590 Filing: 000143774925012093 Input fundies:CapitalExpenditure: 15000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946486/000143774925012093/wint20241231_10k.htm#2469976 Filing: 000143774925012093 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	−USD 1.8 million Exact value Exact value: -1800000 USD 2024-01-01 – 2024-12-31: -1800000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Windtree Therapeutics, Inc. · 2024-12-31 Windtree Therapeutics, Inc. (edgar:946486) Net Income: -1800000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T14:53:36Z Snapshot: 5003797f5474aa120b871d98dfbbc6d4748d8ea1fc18592f3259e4bac817ecb0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/946486/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1800000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946486/000143774925012093/wint20241231_10k.htm#2549523 Filing: 000143774925012093 The citation records this snapshot. The page link may show a newer release later.	−USD 15.4 million Exact value Exact value: -15402000 USD 2024-01-01 – 2024-12-31: -15402000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Windtree Therapeutics, Inc. · 2024-12-31 Windtree Therapeutics, Inc. (edgar:946486) Operating Cash Flow: -15402000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T14:53:36Z Snapshot: 5003797f5474aa120b871d98dfbbc6d4748d8ea1fc18592f3259e4bac817ecb0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/946486/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -15402000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946486/000143774925012093/wint20241231_10k.htm#2465770 Filing: 000143774925012093 The citation records this snapshot. The page link may show a newer release later.	USD 12,000 Exact value Exact value: 12000 USD 2024-01-01 – 2024-12-31: 12000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Windtree Therapeutics, Inc. · 2024-12-31 Windtree Therapeutics, Inc. (edgar:946486) Capital Expenditure: 12000 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T14:53:36Z Snapshot: 5003797f5474aa120b871d98dfbbc6d4748d8ea1fc18592f3259e4bac817ecb0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/946486/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 12000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946486/000143774925012093/wint20241231_10k.htm#2469169 Filing: 000143774925012093 The citation records this snapshot. The page link may show a newer release later.	−USD 15.41 million Calculation and evidence -15402000 − 12000 USD Exact free cash flow: -15414000 USD 2024-01-01 – 2024-12-31: -15402000 USD · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 12000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Windtree Therapeutics, Inc. · 2024-12-31 Windtree Therapeutics, Inc. (edgar:946486) Free cash flow: -15414000 USD Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T14:53:36Z Snapshot: 5003797f5474aa120b871d98dfbbc6d4748d8ea1fc18592f3259e4bac817ecb0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/946486?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -15402000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946486/000143774925012093/wint20241231_10k.htm#2465770 Filing: 000143774925012093 Input fundies:CapitalExpenditure: 12000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946486/000143774925012093/wint20241231_10k.htm#2469169 Filing: 000143774925012093 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

164 filings · 4,469 latest values · 4,469 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000946486, 946486, WINT, edgar:946486, wint

Also known as ANSAN INC, ANSAN PHARMACEUTICALS INC, DISCOVERY LABORATORIES INC /DE/, DISCOVERY LABORATORIES INC /DE/ , WINDTREE THERAPEUTICS INC /DE/, WINDTREE THERAPEUTICS, INC., Windtree Therapeutics, Inc.

Windtree Therapeutics, Inc.

Latest quarter

Revenue

Operating cash flow

Free cash flow

Reported share-count change

Company performance

What changed year over year

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2019 2019-01-01 – 2019-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation